APA (7th ed.) Citation

Yi-Ting Huang, Li-Ting Ho, Li-Ting Ho, Li-Ting Ho, Hsin-Yin Hsu, Hsin-Yin Hsu, . . . Kuo-Liong Chien. (2022). Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yi-Ting Huang, et al. Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Yi-Ting Huang, et al. Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis. Frontiers Media S.A., 2022.